Extract of okra lowers blood glucose and serum lipids in high-fat diet-induced obese C57BL/6 mice

Journal of Nutritional Biochemistry

Volumn 25, Issue 7, 2014, Pages 702-709

  Fan, Shengjie ^a   Zhang, Yu ^a   Sun, Qinhu ^a   Yu, Lijing ^a   Li, Mingxia ^a   Zheng, Bin ^a   Wu, Ximin ^a   Yang, Baican ^a   Li, Yiming ^a   Huang, Cheng ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Diabetes; Hyperlipidemia; Insulin resistance; Okra

Indexed keywords

CELL NUCLEUS RECEPTOR; FLAVONOID; GLUCOSE; INSULIN; ISOQUERCITRIN; LIPID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; QUERCETIN 3 O GENTIOBIOSIDE; UNCLASSIFIED DRUG; DISACCHARIDE; GLUCOSE BLOOD LEVEL; PLANT EXTRACT; QUERCETIN; QUERCETIN 3-O-GENTIOBIOSIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET THERAPY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; IN VITRO STUDY; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; LIPID DIET; MORPHOLOGY; MOUSE; NONHUMAN; OBESITY; OKRA; TRIACYLGLYCEROL BLOOD LEVEL; ABELMOSCHUS; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; C57BL MOUSE; CHEMISTRY; METABOLISM; MOUSE MUTANT;

ABELMOSCHUS; ANIMALS; BLOOD GLUCOSE; DIET, HIGH-FAT; DISACCHARIDES; FEMALE; INSULIN; MICE, INBRED C57BL; MICE, OBESE; OBESITY; PLANT EXTRACTS; PPAR GAMMA; QUERCETIN;

EID: 84901819130     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2014.02.010     Document Type: Article

References (51)

1. Adelakun O.E., Oyelade O.J., Ade-Omowaye B.I., Adeyemi I.A., Van de Venter M. Chemical composition and the antioxidative properties of Nigerian okra seed (Abelmoschus esculentus Moench) flour. Food Chem Toxicol 2009, 47:1123-1126.
2. Liao H., Liu H., Yuan K. A new flavonol glycoside from the Abelmoschus esculentus Linn. Pharmacognosy Magazine 2012, 8:12-15.
3. Adelakun O.E., Oyelade O.J., Ade-Omowaye B.I., Adeyemi I.A., Van de Venter M., Koekemoer T.C. Influence of pre-treatment on yield chemical and antioxidant properties of a Nigerian okra seed (Abelmoschus esculentus moench) flour. Food Chem Toxicol 2009, 47:657-661.
4. Arapitsas P. Identification and quantification of polyphenoliccompounds from okraseeds and skins. Food Chem 2008, 110:1041-1045.
5. Xiao Z.P., Peng Z.Y., Peng M.J., Yan W.B., Ouyang Y.Z., Zhu H.L. Flavonoids health benefits and their molecular mechanism. Mini Rev Med Chem 2011, 11:169-177.
6. Kahlon T.S., Chapman M.H., Smith G.E. In vitro binding of bile acids by okra, beets, asparagus, eggplant, turnips, green beans, carrot and cauliflower. Food Chem 2007, 103:676-680.
7. van Dam R.M., Naidoo N., Landberg R. Dietary flavonoids and the development of type 2 diabetes and cardiovascular diseases: review of recent findings. Curr Opin Lipidol 2013, 24:25-33.
8. Verma A.K., Singh H., Satyanarayana M., Srivastava S.P., Tiwari P., Singh A.B., et al. Flavone-based novel antidiabetic and antidyslipidemic agents. J Med Chem 2012, 55:4551-4567.
9. Wedick N.M., Pan A., Cassidy A., Rimm E.B., Sampson L., Rosner B., et al. Dietary flavonoid intakes and risk of type 2 diabetes in US men and women. Am J Clin Nutr 2012, 95:925-933.
10. Liu I.M., Tzeng T.F., Liou S.S. Abelmoschus moschatus (Malvaceae), an aromatic plant, suitable for medical or food uses to improve insulin sensitivity. Phytother Res 2010, 24:233-239.
11. Liu I.M., Tzeng T.F., Liou S.S., Lan T.W. Improvement of insulin sensitivity in obese Zucker rats by myricetin extracted from Abelmoschus moschatus. Planta Med 2007, 73:1054-1060.
12. Zhou L., An X.F., Teng S.C., Liu J.S., Shang W.B., Zhang A.H., et al. Pretreatment with the total flavone glycosides of flos abelmoschus manihot and hyperoside prevents glomerular podocyte apoptosis in streptozotocin-induced diabetic nephropathy. J Med Food 2012, 15:461-468.
13. Sabitha V., Ramachandran S., Naveen K.R., Panneerselvam K. Antidiabetic and antihyperlipidemic potential of Abelmoschus esculentus (L.) Moench. in streptozotocin-induced diabetic rats. J Pharm Bioallied Sci 2011, 3:397-402.
14. Fan S., Guo L., Zhang Y., Sun Q., Yang B., Huang C. Okra polysaccharide improves metabolic disorders in high-fat diet-induced obese C57BL/6 mice. Mol Nutr Food Res 2013, 57:2075-2078.
15. Okada Y., Okada M., Sagesaka Y. Screening of dried plant seed extracts for adiponectin production activity and tumor necrosis factor-alpha inhibitory activity on 3T3-L1 adipocytes. Plant Foods Hum Nutr 2010, 65:225-232.
16. Field K.J., Lang C.M. Hazards of urethane (ethyl carbamate): a review of the literature. Lab Anim 1988, 22:255-262.
17. Turner R.C., Holman R.R., Matthews D., Hockaday T.D., Peto J. Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations. Metabolism 1979, 28:1086-1096.
18. Fan S., Zhang Y., Hu N., Sun Q., Ding X., Li G., et al. Extract of Kuding tea prevents high-fat diet-induced metabolic disorders in C57BL/6 mice via liver X receptor (LXR) beta antagonism. PloS One 2012, 7:e51007.
19. Sanchez-Moreno C. Review: methods used to evaluate the free radical scavenging activity in foods and biological systems. Food Sci Technol Int 2002, 8:121-137.
20. Neri-Numa I.A., Carvalho-Silva L.B., Morales J.P., Malta L.G., Muramoto M.T., Ferreira J.E.M., et al. Evaluation of the antioxidant, antiproliferative and antimutagenic potential of araca-boi fruit (Eugenia stipitata Mc Vaugh - Myrtaceae) of the Brazilian Amazon Forest. Food Res Int 2013, 50:70-76.
21. Kong Y., Wei Z.F., Fu Y.J., Gu C.B., Zhao C.J., Yao X.H., et al. Negative-pressure cavitation extraction of cajaninstilbene acid and pinostrobin from pigeon pea [Cajanus cajan (L.) Millsp.] leaves and evaluation of antioxidant activity. Food Chem 2011, 128:596-605.
22. Lengsfeld C., Titgemeyer F., Faller G., Hensel A. Glycosylated compounds from okra inhibit adhesion of Helicobacter pylori to human gastric mucosa. J Agric Food Chem 2004, 52:1495-1503.
23. Schulze M.B., Hu F.B. Dietary approaches to prevent the metabolic syndrome: quality versus quantity of carbohydrates. Diabetes Care 2004, 27:613-614.
24. Freireich E.J., Gehan E.A., Rall D.P., Schmidt L.H., Skipper H.E. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother Rep 1966, 50:219-244.
25. Liao H., Dong W., Shi X., Liu H., Yuan K. Analysis and comparison of the active components and antioxidant activities of extracts from Abelmoschus esculentus L. Pharmacogn Mag 2012, 8:156-161.
26. Jeong S.M., Kang M.J., Choi H.N., Kim J.H., Kim J.I. Quercetin ameliorates hyperglycemia and dyslipidemia and improves antioxidant status in type 2 diabetic db/db mice. Nutr Res Pract 2012, 6:201-207.
27. Dai X., Ding Y., Zhang Z., Cai X., Bao L., Li Y. Quercetin but not quercitrin ameliorates tumor necrosis factor-alpha-induced insulin resistance in C2C12 skeletal muscle cells. Biol Pharm Bull 2013, 36:788-795.
28. Youl E., Bardy G., Magous R., Cros G., Sejalon F., Virsolvy A., et al. Quercetin potentiates insulin secretion and protects INS-1 pancreatic beta-cells against oxidative damage via the ERK1/2 pathway. Br J Pharmacol 2010, 161:799-814.
29. Li J.M., Wang W., Fan C.Y., Wang M.X., Zhang X., Hu Q.H., et al. Quercetin preserves beta -cell mass and function in fructose-induced hyperinsulinemia through modulating pancreatic Akt/FoxO1 activation. Evid Based Complement Alternat Med 2013, 2013:303902.
30. Kim J.H., Kang M.J., Choi H.N., Jeong S.M., Lee Y.M., Kim J.I. Quercetin attenuates fasting and postprandial hyperglycemia in animal models of diabetes mellitus. Nutr Res Pract 2011, 5:107-111.
31. Panda S., Kar A. Antidiabetic and antioxidative effects of Annona squamosa leaves are possibly mediated through quercetin-3-O-glucoside. Biofactors 2007, 31:201-210.
32. Wang C., Pan Y., Zhang Q.Y., Wang F.M., Kong L.D. Quercetin and allopurinol ameliorate kidney injury in STZ-treated rats with regulation of renal NLRP3 inflammasome activation and lipid accumulation. PLoS One 2012, 7:e38285.
33. Lai P.B., Zhang L., Yang L.Y. Quercetin ameliorates diabetic nephropathy by reducing the expressions of transforming growth factor-beta1 and connective tissue growth factor in streptozotocin-induced diabetic rats. Ren Fail 2012, 34:83-87.
34. Eid H.M., Martineau L.C., Saleem A., Muhammad A., Vallerand D., Benhaddou-Andaloussi A., et al. Stimulation of AMP-activated protein kinase and enhancement of basal glucose uptake in muscle cells by quercetin and quercetin glycosides, active principles of the antidiabetic medicinal plant Vaccinium vitis-idaea. Mol Nutr Food Res 2010, 54:991-1003.
35. Li Y.Q., Zhou F.C., Gao F., Bian J.S., Shan F. Comparative evaluation of quercetin, isoquercetin and rutin as inhibitors of alpha-glucosidase. J Agric Food Chem 2009, 57:11463-11468.
36. Annapurna A., Reddy C.S., Akondi R.B., Rao S.R. Cardioprotective actions of two bioflavonoids, quercetin and rutin, in experimental myocardial infarction in both normal and streptozotocin-induced type I diabetic rats. J Pharm Pharmacol 2009, 61:1365-1374.
37. Crespy V., Morand C., Besson C., Manach C., Demigne C., Remesy C. Comparison of the intestinal absorption of quercetin, phloretin and their glucosides in rats. J Nutr 2001, 131:2109-2114.
38. Zhang R., Yao Y., Wang Y., Ren G. Antidiabetic activity of isoquercetin in diabetic KK-Ay mice. Nutr Metab (Lond) 2011, 8:85.
39. Tomoda M., Shimizu N., Gonda R., Kanari M., Yamada H., Hikino H. Anticomplementary and hypoglycemic activity of okra and hibiscus mucilages. Carbohydr Res 1989, 190:323-328.
40. Patel R.P., Barnes S. Isoflavones and PPAR signaling: a critical target in cardiovascular, metastatic, and metabolic disease. PPAR Res 2010, 2010:153252.
41. Rogue A., Spire C., Brun M., Claude N., Guillouzo A. Gene expression changes induced by PPAR gamma agonists in animal and human liver. PPAR Res 2010, 2010:325183.
42. Wang Y.X. PPARs: diverse regulators in energy metabolism and metabolic diseases. Cell Res 2010, 20:124-137.
43. Gong Z., Huang C., Sheng X., Zhang Y., Li Q., Wang M.W., et al. The role of tanshinone IIA in the treatment of obesity through peroxisome proliferator-activated receptor gamma antagonism. Endocrinology 2009, 150:104-113.
44. Goto T., Kim Y.I., Takahashi N., Kawada T. Natural compounds regulate energy metabolism by the modulating the activity of lipid-sensing nuclear receptors. Mol Nutr Food Res 2013, 57:20-33.
45. Kubota N., Terauchi Y., Miki H., Tamemoto H., Yamauchi T., Komeda K., et al. PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell 1999, 4:597-609.
46. Jones J.R., Barrick C., Kim K.A., Lindner J., Blondeau B., Fujimoto Y., et al. Deletion of PPARgamma in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance. Proc Natl Acad Sci U S A 2005, 102:6207-6212.
47. Rieusset J., Touri F., Michalik L., Escher P., Desvergne B., Niesor E., et al. A new selective peroxisome proliferator-activated receptor gamma antagonist with antiobesity and antidiabetic activity. Mol Endocrinol 2002, 16:2628-2644.
48. Babu P.V., Liu D., Gilbert E.R. Recent advances in understanding the anti-diabetic actions of dietary flavonoids. J Nutr Biochem 2013, 24:1777-1789.
49. Cook N.C., Samman S. Flavonoids - Chemistry, metabolism, cardioprotective effects, and dietary sources. J Nutr Biochem 1996, 7:66-76.
50. Goto T., Teraminami A., Lee J.Y., Ohyama K., Funakoshi K., Kim Y.I., et al. Tiliroside, a glycosidic flavonoid, ameliorates obesity-induced metabolic disorders via activation of adiponectin signaling followed by enhancement of fatty acid oxidation in liver and skeletal muscle in obese-diabetic mice. J Nutr Biochem 2012, 23:768-776.
51. Pietta P.G. Flavonoids as antioxidants. J Nat Prod 2000, 63:1035-1042.